Tue.Sep 17, 2024

article thumbnail

STAT+: Express Scripts sues FTC over a ‘biased’ report about pharmacy benefit managers

STAT

Express Scripts, one of the largest pharmacy benefit managers in the U.S., filed a lawsuit on Tuesday demanding that a recent Federal Trade Commission report accusing industry middlemen of raising drug prices be vacated. In scathing language, the company argued the report was “seventy-four pages of unsupported innuendo leveled … under a false and defamatory headline.

article thumbnail

How a radiopharma up-and-comer builds momentum in a surging space

PharmaVoice

Big Pharma is embracing the radiopharmaceuticals boom that was a long time in the making.

182
182
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

STAT+: What pharma companies and insurers think about Medicare’s plan to cover digital treatments

STAT

In July, Medicare proposed to start paying for some mental health apps, in a move applauded by the developers of those treatments after years of struggling to find adoption among clinicians and patients. But it wasn’t only the startups and their supporters that took notice — some of the largest pharma and health care companies in the country, like Pfizer and CVS Health, weighed in on the proposal during the comment period, arguing for modifications that suit their vision for how di

article thumbnail

Roundtable: Six months of Pharmacy First

The Pharmacist

Joanna Robertson reports on an exclusive roundtable, held in August this year, which brought together community pharmacy and general practice representatives to discuss the successes, challenges and future of Pharmacy First, six months after the service began in England. Pharmacy First launched in England on 31 January 2024, and sees pharmacists funded to provide advice […] The post Roundtable: Six months of Pharmacy First appeared first on The Pharmacist.

article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

A history of mpox so far

STAT

STAT senior writer Helen Branswell answers the most frequently asked questions about what is happening with mpox now and what can be done to stop this current outbreak.

333
333
article thumbnail

ADC developed by Daiichi, Merck outperforms chemo in lung cancer trial

BioPharma Dive

The FDA previously rejected patritumab deruxtecan over manufacturing issues. Tuesday's study data should boost the companies' case, however.

124
124

More Trending

article thumbnail

Nura Bio gets another $68M, new CEO to advance ‘neuroprotective’ brain drugs

BioPharma Dive

The funding will support mid-stage testing of a drug the company believes to have the potential to treat a range of neurodegenerative conditions.

122
122
article thumbnail

STAT+: From Epic to FDA, all the leaders presenting at HHS’ invite-only AI in health care event

STAT

Federal health officials wrestling with when and how to use artificial intelligence will on Wednesday host an invitation-only meeting of AI leaders across industry, academia, and government. Called “AI in Action: Transforming Health and Human Services,” the three-hour event is hosted by the federal health department. Its agenda illustrates a department excitedly working through how AI fits into its mission — as well as into the United States’ broader health care syste

article thumbnail

UKRI’s MRC awards £27.4m to University of Dundee research unit

Pharma Times

The centre aims to discover new drug targets for diseases such as Parkinson’s and hypertension

121
121
article thumbnail

STAT+: U.S. agency threatens J&J with sanctions if it switches payments to 340B hospitals

STAT

A U.S. government agency has threatened Johnson & Johnson with sanctions if the company proceeds with plans to alter payment methods for some hospitals that participate in a federal drug discount program. In a letter sent on Tuesday, the U.S. Health Resources and Services Administration maintained that a J&J plan to issue rebates for two widely prescribed medicines instead of offering discounted prices would violate federal law.

Hospitals 314
article thumbnail

Why Every Small Business Needs an HCM Solution: A Comprehensive Guide

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

article thumbnail

Ascendis trial data piles pressure on BioMarin

BioPharma Dive

Summary study results show Ascendis’ drug for achondroplasia could be competitive to BioMarin's Voxzogo, which is the foundation of the latter company's growth plans.

113
113
article thumbnail

STAT+: 11 people shaping psychedelics drug development

STAT

The field of psychedelics, once relegated to the fringes of science and medicine, is in the midst of both transformation and flux. Several key figures stand out in their efforts to push forward the advancement of psychedelic medicine, in the face of ongoing controversy , regulatory hurdles , and stigma. Psychiatric medicine hasn’t seen much innovation in recent decades, even as many say that drugs like psilocybin, MDMA, and DMT can offer real hope to millions of people who suffer from men

article thumbnail

Government looking at pharmacy contract 'as matter of urgency'

The Pharmacist

The government is looking at the negotiations around community pharmacy funding and contractual framework arrangements for 2024/25 'as a matter of urgency', the parliamentary under-secretary for health and social care has said. Responding to a written question from Conservative peer Lord Bourne of Aberystwyth, Baroness Merron noted that the 'consultation with Community Pharmacy England on […] The post Government looking at pharmacy contract 'as matter of urgency' appeared first o

article thumbnail

FDA awards Novartis expanded approval for breast cancer therapy

STAT

Kisqali, a key targeted therapy for breast cancer from Novartis, until now has been indicated only for patients with metastatic disease. But on Tuesday, the Food and Drug Administration approved Kisqali in combination with hormone therapy for patients with certain early-stage breast cancers, significantly expanding the number of patients who will have access to this type of drug.

289
289
article thumbnail

Best Practices to Streamline Compensation Management: A Foundation for Growth

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

article thumbnail

Trial sets up filings for Boehringer IPF drug nerandolimast

pharmaphorum

Boehringer will file its idiopathic pulmonary fibrosis drug nerandolimast next year, a successor to its blockbuster Ofev, after a phase 3 win

110
110
article thumbnail

FDA formalizes protocol for international cancer trials

STAT

Want to stay on top of the science and politics driving biotech today?  Sign up  to get our biotech newsletter in your inbox. Good morning. I’m in New York this week with my colleague Adam Feuerstein for the Cantor Fitzgerald Healthcare Conference. Say hi if you’re there and you see us!

article thumbnail

Tobacco firm PMI divests Vectura at a loss after backlash

pharmaphorum

Tobacco giant PMI is selling pharma unit Vectura for a fraction of the £1.

109
109
article thumbnail

STAT+: Pharmalittle: We’re reading about an Express Scripts lawsuit against FTC, AMR deaths, and more

STAT

Top of the morning to you, and a fine one it is, despite the gray skies hovering over the Pharmalot campus. We are doing our best to maintain sunny spirits, though, because once again, we recall some helpful wisdom from the Morning Mayor, who taught us that “every new day should be unwrapped like a precious gift.” To celebrate the notion, we are brewing still more cups of stimulation and inviting you to join us.

article thumbnail

Enhance Healthcare Efficiency With Top Payroll & HCM Services

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

article thumbnail

Mitigating diagnostic errors in clinical trial participants: The role of drug safety/pharmacovigilance

pharmaphorum

Mitigating diagnostic errors in clinical trial participants: The role of drug safety/pharmacovigilance Mike.

108
108
article thumbnail

F2G raises $100 million to combat innovation 'paucity in antifungals

Outsourcing Pharma

One year after a rejection by the US Food and Drug Administration (FDA), the UK firm F2G has raised $100 million to push its candidate olorofim to the market for the treatment of rare fungal infections in 2026.

107
107
article thumbnail

FDA clears sleep apnoea feature for new Apple Watch

pharmaphorum

Apple has the FDA authorisation it needs to bring its software for detecting sleep apnoea to the Apple Watch, coinciding with the launch of its new operating system for the wearable.The Breathing Disturbances function is part of watchOS 11, which makes its debut today alongside the release of the latest Apple Watch Series 10 which was revealed at the company's new product reveal earlier this month and is due to become available on 20th September.

105
105
article thumbnail

Manufacturing the right talent

Express Pharma

Known as the “Pharmacy of the world”, India is a hub for pharma manufacturing and occupies a hefty 20 per cent share in the global generics volume supply by manufacturing 60,000 different generic brands across 60 therapeutic areas. The industry is poised for considerable growth in the near future and is expected to reach $130 billion by 2030 (currently valued at $50 billion) (1).

article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

How Do White Label Products Work for Pharmacies?

PioneerRx

As you well know, there are countless ways to make more money for your pharmacy. From leveraging your pharmacy technology to expanding your clinical services.

Labelling 103
article thumbnail

Neovantage Innovation Parks secures a green loan for its life sciences real estate portfolio

Express Pharma

Neovantage Innovation Parks has secured its inaugural green loan of Rs 300 crores (~C$ 50 million) from HSBC India. This is HSBC’s first green loan facility in the life sciences real estate sector in India. It was awarded on the back of Neovantage Innovation Parks’ commitment to eco-innovation and sustainable operations across its properties. Neovantage Innovation Parks has achieved this by maintaining all its operating buildings a Gold or higher rating under the LEED for Operations and Maintena

104
104
article thumbnail

Boehringer Ingelheim score with phase 3 idiopathic pulmonary fibrosis win

Outsourcing Pharma

The German big pharma will submit a new drug application to the US FDA after success at phase 3 for nerandomilast.

98
article thumbnail

Podcast: How drones are transforming the clinical supply chain in Africa

Pharmaceutical Technology

Drones are starting to play a vital role in the clinical supply chain across sub-Saharan Africa to reach more patients.

98
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

After FDA no, MSD/Daiichi post new data with lung cancer ADC

pharmaphorum

MSD and Daiichi Sankyo's patritumab deruxtecan hit its main objective in a phase 3 lung cancer study that reinforces its potential as a new treatment option for patients after first-line treatment with EGFR inhibitors.The HERTHENA-Lung02 study in EGFR-mutated non-small cell lung cancer (NSCLC), involving patients with locally advanced or metastatic disease previously treated with EGFR drugs, revealed a significant improvement in progression-free survival (PFS) compared to a chemotherapy regimen.

article thumbnail

FDA grants RMAT to Poseida’s CAR-T cell therapy P-BCMA-ALLO1

Pharmaceutical Technology

Poseida Therapeutics has received RMAT designation from the US FDA for its CAR-T cell therapy, P-BCMA-ALLO1.

96
article thumbnail

Up to one-third of antibody drugs are nonspecific

World Pharma News

Integral Molecular, a leader in antibody discovery and characterization, has published new research in the journal mAbs, revealing that as many as one-third of antibody-based drugs exhibit nonspecific binding to unintended targets. A serious concern, off-target drug binding is a significant cause of adverse events in patients, with the potential to even cause death.

78
article thumbnail

uMotif expands site and patient platform with ClinOne acquisition

Outsourcing Pharma

uMotif, a fast-growing company in the clinical research technology sector, has taken a significant step in expanding its platform with the acquisition of ClinOne, a provider of site platform solutions.

77
article thumbnail

FDA Grants Fast Track Designation to Non-Opioid Treatment for Osteoarthritis Knee Pain

Pharmaceutical Commerce

FDA fast tracks Sun Pharma and Moebius Medical’s MM-II treatment for osteoarthritis knee pain, with Phase III clinical trials planned to expedite a potential approval.

75